Home
/
Bolt Biotherapeutics, Inc.
/
Financials
/
Quarterly
Bolt Biotherapeutics, Inc. — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that Bolt Biotherapeutics, Inc. filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$2.17M
Nov 12, 2025
Q2
2025
Jun 30, 2025
$1.80M
Aug 14, 2025
Q1
2025
Mar 31, 2025
$1.22M
May 12, 2025
Q3
2025
Sep 30, 2024
$1.14M
Nov 12, 2025
Q2
2025
Jun 30, 2024
$1.28M
Aug 14, 2025
Q1
2025
Mar 31, 2024
$5.27M
May 12, 2025
Q3
2024
Sep 30, 2023
$2.53M
Nov 12, 2024
Q2
2024
Jun 30, 2023
$1.43M
Aug 13, 2024
Q1
2024
Mar 31, 2023
$1.83M
May 14, 2024
Q3
2023
Sep 30, 2022
$2.11M
Nov 9, 2023
Q2
2023
Jun 30, 2022
$1.39M
Aug 7, 2023
Q1
2023
Mar 31, 2022
$813.0K
May 11, 2023
Q3
2022
Sep 30, 2021
$752.0K
Nov 10, 2022
Q2
2021
Jun 30, 2021
$0
Aug 12, 2021
Q3
2021
Sep 30, 2020
$231.0K
Nov 9, 2021
Q2
2021
Jun 30, 2020
$67.0K
Aug 12, 2021
Q1
2021
Mar 31, 2020
$164.0K
May 13, 2021
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($7.14M)
Nov 12, 2025
Q2
2025
Jun 30, 2025
($8.56M)
Aug 14, 2025
Q1
2025
Mar 31, 2025
($11.04M)
May 12, 2025
Q3
2025
Sep 30, 2024
($15.18M)
Nov 12, 2025
Q2
2025
Jun 30, 2024
($21.20M)
Aug 14, 2025
Q1
2025
Mar 31, 2024
($10.81M)
May 12, 2025
Q3
2024
Sep 30, 2023
($16.26M)
Nov 12, 2024
Q2
2024
Jun 30, 2023
($18.06M)
Aug 13, 2024
Q1
2024
Mar 31, 2023
($16.98M)
May 14, 2024
Q3
2023
Sep 30, 2022
($21.76M)
Nov 9, 2023
Q2
2023
Jun 30, 2022
($22.66M)
Aug 7, 2023
Q1
2023
Mar 31, 2022
($23.68M)
May 11, 2023
Q3
2022
Sep 30, 2021
($23.40M)
Nov 10, 2022
Q2
2022
Jun 30, 2021
($23.59M)
Aug 10, 2022
Q1
2022
Mar 31, 2021
($24.45M)
May 12, 2022
Q3
2021
Sep 30, 2020
($10.00M)
Nov 9, 2021
Q2
2021
Jun 30, 2020
($11.06M)
Aug 12, 2021
Q1
2021
Mar 31, 2020
($8.63M)
May 13, 2021
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($7.70M)
Nov 12, 2025
Q2
2025
Jun 30, 2025
($9.21M)
Aug 14, 2025
Q1
2025
Mar 31, 2025
($12.12M)
May 12, 2025
Q3
2025
Sep 30, 2024
($16.44M)
Nov 12, 2025
Q2
2025
Jun 30, 2024
($22.60M)
Aug 14, 2025
Q1
2025
Mar 31, 2024
($17.09M)
May 12, 2025
Q3
2024
Sep 30, 2023
($18.18M)
Nov 12, 2024
Q2
2024
Jun 30, 2023
($19.83M)
Aug 13, 2024
Q1
2024
Mar 31, 2023
($18.42M)
May 14, 2024
Q3
2023
Sep 30, 2022
($22.35M)
Nov 9, 2023
Q2
2023
Jun 30, 2022
($23.06M)
Aug 7, 2023
Q1
2023
Mar 31, 2022
($23.88M)
May 11, 2023
Q3
2022
Sep 30, 2021
($23.53M)
Nov 10, 2022
Q2
2022
Jun 30, 2021
($23.76M)
Aug 10, 2022
Q1
2022
Mar 31, 2021
($18.43M)
May 12, 2022
Q3
2021
Sep 30, 2020
($12.41M)
Nov 9, 2021
Q2
2021
Jun 30, 2020
($11.11M)
Aug 12, 2021
Q1
2021
Mar 31, 2020
($8.75M)
May 13, 2021